Cargando…

ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the Literature

Since 2007, a new class of biologic products for human use called “advanced therapy medicinal products (ATMP)” have been legally integrated in the European Medical Agency. They consist of recombinant nucleic acid, engineered cells, cells, or tissues. In the United States, ATMP fall under the regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damerval, Margaux, Fagnoni-Legat, Christine, Louvrier, Aurélien, Fischer, Sarah, Limat, Samuel, Clairet, Anne-Laure, Nerich, Virginie, Madelaine, Isabelle, Kroemer, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671638/ https://www.ncbi.nlm.nih.gov/pubmed/34926483 http://dx.doi.org/10.3389/fmed.2021.713047

Ejemplares similares

Surgery Versus ATMPs: An Example From Ophthalmology
por: Magrelli, Federica M., et al.
Publicado: (2020)

RESTORE Survey on the Public Perception of Advanced Therapies and ATMPs in Europe—Why the European Union Should Invest More!
por: Goldsobel, Gady, et al.
Publicado: (2021)

Approval of First CAR-Ts: Have we Solved all Hurdles for ATMPs?
por: Seimetz, Diane, et al.
Publicado: (2019)

EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation
por: Detela, Giulia, et al.
Publicado: (2019)

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
por: Calcagno, Fabien, et al.
Publicado: (2016)

Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium
por: Berisa-Prado, Silvia, et al.
Publicado: (2021)

Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective
por: Barker, Roger A., et al.
Publicado: (2021)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020)

Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
por: Muthu, Sathish, et al.
Publicado: (2022)

COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
por: Kroemer, Marie, et al.
Publicado: (2021)

A Regulatory Risk-Based Approach to ATMP/CGT Development: Integrating Scientific Challenges With Current Regulatory Expectations
por: Salazar-Fontana, Laura I.
Publicado: (2022)

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
por: Silva, D.N., et al.
Publicado: (2022)

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 T(H)1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
por: Rebucci-Peixoto, Magali, et al.
Publicado: (2022)

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
por: Walcher, Lia, et al.
Publicado: (2021)

Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP)
por: Zscharnack, Matthias, et al.
Publicado: (2015)

Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)—An In Vivo Animal Trial
por: Köhnke, Robert, et al.
Publicado: (2021)

Abstract 16 New Advanced Therapy Medicinal Products (ATMPs) in Medical Trials: A FamiCord Group Development Pipeline Update
por: Gerth, André, et al.
Publicado: (2022)

“I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients
por: Litchfield, Ian, et al.
Publicado: (2023)

Evaluating Ecological Impact and Sustainability in the Manufacturing of Advanced Therapies: Comparative Analysis of Greenhouse Gas Emissions in the Production of ATMPs in Open and Closed Systems
por: Pinnetta, Giuseppe, et al.
Publicado: (2023)

German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30
por: Kemmler, Georg, et al.
Publicado: (2019)

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial
por: Pozet, Astrid, et al.
Publicado: (2016)

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients
por: Pozet, Astrid, et al.
Publicado: (2023)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Pancytopenia in a patient treated with fusidic acid and niraparib: a case report
por: Damerval, Margaux, et al.
Publicado: (2023)

3D printing as a pedagogical tool for teaching normal human anatomy: a systematic review
por: Brumpt, Eléonore, et al.
Publicado: (2023)

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
por: Nerich, Virginie, et al.
Publicado: (2014)

Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration
por: Gentile, Pietro, et al.
Publicado: (2020)

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)
por: Vienot, Angélique, et al.
Publicado: (2023)

MRSA prevalence in european healthcare settings: a review
por: Dulon, Madeleine, et al.
Publicado: (2011)

Process data of allogeneic ex vivo-expanded ABCB5(+) mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
por: Ballikaya, Seda, et al.
Publicado: (2020)

Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
por: McMullan, Christel, et al.
Publicado: (2023)

In silico identification and in vitro assessment of a potential anti-breast cancer activity of antimicrobial peptide retrieved from the ATMP1 Anabas testudineus fish peptide
por: Law, Douglas, et al.
Publicado: (2023)

Comparative Analysis of the Results of Stroke Treatment With Multiple Administrations of Wharton’s Jelly Mesenchymal Stem Cells–Derived HE-ATMP and Standard Conservative Treatment: Case Series Study
por: Milczarek, Olga, et al.
Publicado: (2023)

BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
por: Poussard, Margaux, et al.
Publicado: (2020)

Factors Associated with Health-Related Quality of Life in Women with Breast Cancer in the Middle East: A Systematic Review
por: El Haidari, Rana, et al.
Publicado: (2020)

Health-Related Quality of Life of Lebanese Women With Breast Cancer: Protocol for a Prospective Cohort Study
por: El Haidari, Rana, et al.
Publicado: (2021)

La maleficio /
por: Limat, Maurice
Publicado: (1979)

Does Penicillin Allergy Increase the Risk of Surgical Site Infection after Orthognathic Surgery? A Multivariate Analysis
por: Bertin, Eugénie, et al.
Publicado: (2022)

The environmental impacts of different mask options for healthcare settings in the UK
por: Chau, Charnett, et al.
Publicado: (2022)

Environmental approaches to controlling Clostridioides difficile infection in healthcare settings
por: Carling, Philip C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqk6gls8uhpgrs4253q9l2pmts